Centessa Pharmaceuticals PLC - ADR
General ticker "CNTA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $2.0B
Centessa Pharmaceuticals PLC - ADR follows the US Stock Market performance with the rate: 55.2%.
Estimated limits based on current volatility of 4.2%: low 16.42$, high 17.88$
Factors to consider:
- Current price 52.1% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [5.36$, 11.52$]
- 2024-12-30 to 2025-12-30 estimated range: [5.19$, 11.19$]
Financial Metrics affecting the CNTA estimates:
- Negative: Non-GAAP EPS, $ of -1.57 <= 0.10
- Negative: Operating profit margin, % of -96.15 <= 1.03
- Negative: Operating cash flow per share per price, % of -19.53 <= 2.35
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term CNTA quotes
Long-term CNTA plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $6.85MM |
| Operating Expenses | $374.08MM | $212.26MM | $178.14MM |
| Operating Income | $-374.08MM | $-212.26MM | $-171.28MM |
| Non-Operating Income | $-6.87MM | $-4.69MM | $-4.86MM |
| Interest Expense | $2.55MM | $7.03MM | $9.91MM |
| R&D Expense | $96.31MM | $155.08MM | $124.41MM |
| Income(Loss) | $-380.96MM | $-216.95MM | $-176.14MM |
| Taxes | $0.11MM | $-0.75MM | $-25.06MM |
| Profit(Loss) | $-381.07MM | $-216.21MM | $-151.09MM |
| Stockholders Equity | $491.55MM | $336.17MM | $236.24MM |
| Inventory | $17.81MM | $29.99MM | $0.00MM |
| Assets | $629.63MM | $444.31MM | $360.25MM |
| Operating Cash Flow | $-136.14MM | $-200.55MM | $-160.34MM |
| Capital expenditure | $0.19MM | $1.14MM | $0.17MM |
| Investing Cash Flow | $63.25MM | $-0.93MM | $-127.00MM |
| Financing Cash Flow | $660.07MM | $0.46MM | $21.12MM |
| Earnings Per Share* | $-4.24 | $-2.31 | $-1.57 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.